Therapy of advanced esophageal malignancy

Current Opinion in Gastroenterology

Volumn 20, Issue 4, 2004, Pages 391-396

  Von Rahden, Burkhard H A ^a   Stein, Hubert J ^a,b  

^a Orthop Klin   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenocarcinoma; Esophageal cancer; Squamous cell cancer; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CHYLOTHORAX; ENDOSCOPIC ECHOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; PERIOPERATIVE PERIOD; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION; VOCAL CORD PARALYSIS;

EID: 3042550034     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200407000-00016     Document Type: Review

References (46)

1. Jacobson BC, Hirota W, Baron TH, et al.: Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003, 57:817-822. Useful practice guideline for the use of endoscopy in esophageal cancer patients.
2. Brown WA, Thomas J, Gotley D, et al.: Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy. Br J Surg 2004, 91:199-204. A study that challenges the routine use of endoscopy after neoadjuvant treatment for esophageal cancer.
3. Stein HJ, Brucher BL, Sendler A, et al.: Esophageal cancer: patient evaluation and pre-treatment staging. Surg Oncol 2001, 10:103-111.
4. Vazquez-Sequeiros E, Wiersema MJ, Clain JE, et al.: Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 2003, 125:1626-1635. Prospective data from the Mayo Clinic/Rochester regarding esophageal cancer staging, with a clear vote for EUS-FNA to be adopted to the preoperative staging algorithm.
5. Chang KJ, Soetikno RM, Bastas D, et al.: Impact of endoscopic ultrasound combined with fine-needle aspiration biopsy in the management of esophageal cancer. Endoscopy 2003, 35:962-966.
6. Funai T, Osugi H, Higashino M, et al.: Estimation of lymph node metastasis by size in patients with intrathoraoic oesophageal cancer. Br J Surg 2000, 87:1234-1239.
7. Mariette C, Balon JM, Maunoury V, et al.: Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg 2003, 90:1367-1372.
8. Preston SR, Clark GW, Martin IG, et al.: Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma. Br J Surg 2003, 90:1220-1224.
9. Downey RJ, Akhurst T, Ilson D, et al.: Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003, 21:428-432. Prospective data evaluating FDG-PET for staging and response evaluation during multimodality treatment.
10. Kneist W, Schreckenberger M, Bartenstein P, et al.: Positron emission tomography for staging esophageal cancer: does it lead to a different therapeutic approach? World J Surg 2003, 27:1105-1112. Critical reappraisal of FDG-PET for esophageal cancer staging. The debate concerning its value is ongoing.
11. Rasanen JV, Sihvo EI, Knuuti MJ, et al.: Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003, 10:954-960.
12. Stein HJ, Siewert JR: Improved prognosis of resected esophageal cancer. World J Surg 2004, in press.
13. Hulscher JB, van Sandick JW, de Boer AG, et al.: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347:1662-1669.
14. Rentz J, Bull D, Harpole D, et al.: Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 2003, 125:1114-1120. A large prospective multicenter study comparing the two major approaches to esophagectomy and showing no differences.
15. Siewert JR, Stein HJ, Feith M: Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett's cancer). World J Surg 2003, 27:1058-1061.
16. Rizk NP, Bach PB, Schrag D, et al.: The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg 2004, 198:42-50. A detailed analysis that convincingly shows a negative effect of postoperative morbidity on long-term survival.
17. Davis PA, Law S, Wong J: Colonic interposition after esophagectomy for cancer. Arch Surg 2003, 138:303-308.
18. Walther B, Johansson J, Johnsson F, et al.: Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg 2003, 238:803-812. A small but nicely performed Swedish prospective randomized trial showing no differences between cervical and high intrathoracic anastomosis after esophagectomy in terms of morbidity, mortality, functional results, and long-term outcome.
19. Siewert JR, Stein HJ: Lymphadenectomy for esophageal cancer. Langenbecks Arch Surg 1999, 384:141-148.
20. Tachibana M, Kinugasa S, Yoshimura H, et al.: Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 2003, 138:1383-1389.
21. Igaki H, Tachimori Y, Kato H: Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 2004, 239:483-490.
22. Burian M, Stein HJ, Sendler A, et al.: Sentinel lymph node detection in Barrett's and cardia cancer. Ann Surg Oncol 2004, 11:255S-8S. A report outlining the principles and feasibility of sentinel lymph node detection and removal in patients with esophageal adenocarcinoma.
23. Feith M, Stein HJ, Siewert JR: Pattern of lymphatic spread in Barrett's cancer. World J Surg 2003, 27:1052-1057. A detailed analysis of the pattern of lymphatic spread in patients with esophageal adenocarcinoma, indicating that "skip metastases" are rare.
24. Kato H, Miyazaki T, Nakajima M, et al.: Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 2003, 98:932-939. A study showing the potential use of sentinel lymphadenectomy in patients with squamous cell esophageal cancer.
25. Matsumoto M, Natsugoe S, Ishigami S, et al.: Rapid immunohistochemical detection of lymph node micrometastasis during operation for upper gastrointestinal carcinoma. Br J Surg 2003, 90:563-566.
26. Birkmeyer JD, Siewers AE, Finlayson EV, et al.: Hospital volume and surgical mortality in the United States. N Engl J Med 2002, 346:1128-1137.
27. Birkmeyer JD, Stukel TA, Siewers AE, et al.: Surgeon volume and operative mortality in the United States. N Engl J Med 2003, 349:2117-2127. Reload of the previous study [26] about hospital volume and association with surgical mortality, now addressing "surgeon volume." The surgeon's experience with esophagectomy is clearly a major factor determining postoperative outcome.
28. Luketich JD, Alvelo-Rivera M, Buenaventura PO, et al.: Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003, 238:486-494. Largest series of minimally-invasive esophagectomies in 222 patients. Despite the amazingly promising results from this experienced center, this technique is faraway from suitability for widespread use.
29. Osugi H, Takemura M, Higashino M, et al.: Learning curve of video-assisted thoracoscopic esophagectomy and extensive lymphadenectomy for squamous cell cancer of the thoracic esophagus and results. Surg Endosc 2003, 17:515-519. An analysis of minimally-invasive esophagectomy in two time periods, clearly showing the learning curve for this procedure.
30. Wong SK, Chan AC, Lee DW, et al.: Minimal invasive approach of gastric and esophageal mobilization in total pharyngolaryngoesophagectomy: total laparoscopic and hand-assisted laparoscopic technique. Surg Endosc 2003, 17:798-802.
31. McCulloch P, Ward J, Tekkis PP: ASCOT group of surgeons; British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastrooesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 2003, 327:1192-1197. A large-scale multicenter cohort study of factors related to postoperative morbidity and mortality after esophagectomy.
32. Murthy SC, Law S, Whooley BP, et al.: Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality. J Thorac Cardiovasc Surg 2003, 126:1162-1167.
33. Chandrashekar MV, Irving M, Wayman J, et al.: Immediate extubation and epidural analgesia allow safe management in a high-dependency unit after two-stage oesophagectomy: results of eight years of experience in a specialized upper gastrointestinal unit in a district general hospital. Br J Anaesth 2003, 90:474-479.
34. Margolis M, Alexander P, Trachiotis GD, et al.: Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg 2003, 76:1694-1697.
35. Lordick F, Stein HJ, Peschel C, et al.: Neoadjuvant therapy in oesophagogastric cancer. Br J Surg 2004, in press.
36. Ando N, Iizuka T, Ide H, et al.: Japan Clinical Oncology Group. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study - JCOG9204. J Clin Oncol 2003, 21:4592-4596. Prospective randomized trial of adjuvant chemotherapy in squamous cell esophageal squamous cancer showing a prolonged disease-free survival with adjuvant chemotherapy. The effect on overall survival was not significant.
37. Rice TW, Adelstein DJ, Chidel MA, et al.: Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 2003, 126:1590-1596.
38. Tachibana M, Yoshimura H, Kinugasa S, et al.: Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur J Surg Oncol 2003, 29:580-587.
39. Urschel JD, Vasan H: A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185:538-543.
40. Kaklamanos IG, Walker GR, Ferry K, et al.: Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003, 10:754-761. Meta-analysis addressing the ongoing controversial debate about neoadjuvant treatment.
41. Wieder HA, Brucher BL, Zimmermann F, et al.: Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004, 22:900-908. A small but interesting study showing that response to neoadjuvant treatment can be reliably predicted as early as 2 weeks after the onset of neoadjuvant therapy. This observation allows stratification of subsequent treatment according to response.
42. Kostopoulos PP, Zissis MI, Polydorou AA, et al.: Are metal stents effective for palliation of malignant dysphagia and fistulas? Dig Liver Dis 2003, 35:275-282.
43. Sabharwal T, Hamady MS, Chui S, et al.: A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003, 52:922-966.
44. Mosca F, Consoli A, Stracqualursi A, et al.: Comparative retrospective study on the use of plastic prostheses and self-expanding metal stents in the palliative treatment of malignant strictures of the esophagus and cardia. Dis Esophagus 2003, 16:119-125.
45. Sarper A, Oz N, Cihangir C, et al.: The efficacy of self-expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur J Cardiothorac Surg 2003, 23:794-798.
46. Kitajima M, Kitagawa Y: Surgical treatment of esophageal cancer: the advent of the era of individualization. N Engl J Med 2002, 347:1705-1709.